drugset / Trial / NCT05311475
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The trial will be conducted as a prospective, randomized, multinational, multicenter, double-blind, placebo and active controlled trial in 4 parallel-groups of patients suffering from seasonal allergic rhinitis.
Timeline
- Start
- 2022-04-04
- Primary completion
- 2023-06-20
- Completion
- 2023-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelastine | Small molecule | 140 ug | Intranasal |
| Subject | Mometasone | Other / unclassified | 50 ug | Intranasal |